Christopher D.  Payne net worth and biography

Christopher Payne Biography and Net Worth

Director of Hims & Hers Health
Christopher Payne has been a member of our Board of Directors since March 2024. He is a proven leader with more than three decades of software and technology experience. He previously served as the President and Chief Operating Officer of DoorDash from 2016 to 2023. Prior to his time at DoorDash, he served as the CEO of Tinder. He also served as Senior Vice President at eBay after he sold his company, Positronic, to the online retailer in 2008. Mr. Payne has also held leadership positions at Microsoft and Amazon, and currently serves on the board of directors of Gogo. He holds a B.A. in US History from Dartmouth College.

What is Christopher D. Payne's net worth?

The estimated net worth of Christopher D. Payne is at least $3.68 million as of May 22nd, 2024. Mr. Payne owns 110,000 shares of Hims & Hers Health stock worth more than $3,675,430 as of March 26th. This net worth approximation does not reflect any other assets that Mr. Payne may own. Learn More about Christopher D. Payne's net worth.

How do I contact Christopher D. Payne?

The corporate mailing address for Mr. Payne and other Hims & Hers Health executives is 2269 CHESTNUT STREET SUITE 523, SAN FRANCISCO CA, 94123. Hims & Hers Health can also be reached via phone at 415-851-0195 and via email at hims-ir@westwicke.com. Learn More on Christopher D. Payne's contact information.

Has Christopher D. Payne been buying or selling shares of Hims & Hers Health?

Christopher D. Payne has not been actively trading shares of Hims & Hers Health during the past quarter. Most recently, on Wednesday, May 22nd, Christopher D. Payne bought 110,000 shares of Hims & Hers Health stock. The stock was acquired at an average cost of $17.7433 per share, with a total value of $1,951,763.00. Following the completion of the transaction, the director now directly owns 110,000 shares of the company's stock, valued at $1,951,763. Learn More on Christopher D. Payne's trading history.

Who are Hims & Hers Health's active insiders?

Hims & Hers Health's insider roster includes Jack Abraham (Major Shareholder), Melissa Baird (COO), Soleil Boughton (Insider), Patrick Carroll (Insider), Michael Chi (Chief Commercial Officer), Andrew Dudum (Co-Founder, Chairman & CEO), Spencer Lee (CFO), Anja Manuel (Director), Oluyemi Okupe (CFO), Christopher Payne (Director), and David Wells (Director). Learn More on Hims & Hers Health's active insiders.

Are insiders buying or selling shares of Hims & Hers Health?

In the last year, Hims & Hers Health insiders bought shares 3 times. They purchased a total of 115,000 shares worth more than $2,084,023.00. In the last year, insiders at the sold shares 87 times. They sold a total of 3,821,427 shares worth more than $93,197,218.35. The most recent insider tranaction occured on March, 18th when insider Patrick Harrison Carroll sold 23,287 shares worth more than $798,976.97. Insiders at Hims & Hers Health own 17.7% of the company. Learn More about insider trades at Hims & Hers Health.

Information on this page was last updated on 3/18/2025.

Christopher D. Payne Insider Trading History at Hims & Hers Health

See Full Table

Christopher D. Payne Buying and Selling Activity at Hims & Hers Health

This chart shows Christopher D Payne's buying and selling at Hims & Hers Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$1M$0$1MTotal Insider BuyingTotal Insider Selling

Hims & Hers Health Company Overview

Hims & Hers Health logo
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Read More

Today's Range

Now: $33.39
Low: $33.25
High: $37.95

50 Day Range

MA: $39.66
Low: $27.80
High: $68.87

2 Week Range

Now: $33.39
Low: $11.20
High: $72.98

Volume

16,241,156 shs

Average Volume

22,558,303 shs

Market Capitalization

$7.42 billion

P/E Ratio

75.90

Dividend Yield

N/A

Beta

1.37